# Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion

> **NCT01256801** · — · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 36 (actual)

## Conditions studied

- Breast Neoplasms
- Neoplasm Metastasis
- Gene Expression Profiling
- Immunotherapy

## Interventions

- **BIOLOGICAL:** cytokine

## Key facts

- **NCT ID:** NCT01256801
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256801, "Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01256801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*